Clinical Trial Update: Evaluate the Safety of Neuronata-R® Inj. Suspended With HypoTHermosol® FRS (HTS-FRS) in Patients With ALS [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety of Neuronata-R with HypoTHermosol FRS in amyotrophic lateral sclerosis has been suspended; no results are reported yet in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• HypoTHermosol FRS (HTS-FRS)
• Neuronata-R Inj.

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED